Related Experiment Video

Updated: Mar 8, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

14.9K

Combination of endovascular graft exclusion and drug therapy in AAA with hypertension or hyperglycemia

Dile Wang1, Bihui Qu1, Tao He2

  • 1Department of Vascular Surgery, Key Laboratory for Molecular Diagnosis of Hubei Province, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Minerva Cardioangiologica
|February 2, 2017
PubMed

Insights

Combining endovascular graft exclusion with medications for hypertension or hyperglycemia significantly reduces abdominal aortic aneurysm (AAA) size. This combination therapy offers a more effective treatment for AAA than endovascular graft exclusion alone.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Endocrinology

Background:

  • Abdominal aortic aneurysm (AAA) poses significant health risks.
  • Managing comorbidities like hypertension and hyperglycemia is crucial in AAA treatment.

Purpose of the Study:

  • To evaluate the efficacy of combining endovascular graft exclusion with antihypertensive and antidiabetic drugs for AAA treatment.
  • To assess the impact of these combined therapies on AAA size and relevant biomarkers.

Main Methods:

  • Analysis of 156 patients with AAA, divided into hypertensive (84) and hyperglycemic (72) cohorts.
  • Hypertensive patients received endovascular graft exclusion followed by cyclopenthiazide, reserpine, propranolol, or placebo.
  • Hyperglycemic patients received endovascular graft exclusion followed by metformin, insulin, or placebo.

Main Results:

  • Endovascular graft exclusion led to AAA size reduction in all groups.
  • Combined drug therapies (cyclopenthiazide, reserpine, propranolol, metformin, insulin) further reduced blood pressure and blood sugar levels, respectively.
  • Significant AAA size reduction was observed with combined therapies compared to placebo (P<0.0001).

Conclusions:

  • Combination therapy of endovascular graft exclusion with antihypertensive or antidiabetic medications is more effective for AAA treatment.
  • This integrated approach enhances therapeutic outcomes for patients with abdominal aortic aneurysms and comorbid conditions.
Abstract

More Related Videos

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

610
Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

16.3K

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
422
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
556
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
526
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
469
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540